Name Patient Supply

With rapidly changing lifestyle and ever increasing stress levels, disease patterns have seen a shift towards rarer and more un-common disease. These disease needs special medicines which are classified as Orphan drugs, Unlicensed Drugs or Special drugs as per WHO.

Demand for such drugs has created an unmet need in the market, which needs to be filled immediately.

Being one of the few WHO GDP certified distributors in India, GNH India has taken the lead to fulfil this “Unmet need” in Indian Market.

GNH India has an expert team and world class infrastructure to source these medicines from across the globe.

 

Name Patient Process

  1. Patients or Physician request for medicines
  2. Internal processing of prescription verifications at GNH India
  3. Identify an optimal source for the particular medicine.
  4. Import the drug under GDP conditions
  5. Dispatch medicines to concerned physician after QA checks.

 

 Apply Online for Name Patient Supply

Upload your Doctor’s prescription here, will validate and get back to you.

Apply Now

Other Pharmaceutical Products

Cladribine (Cladrim) - Injection - 10 mg

Cladribine (Cladrim) - Injection - 10 mg

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Edatate Calcium Disodium Injection USP 200mg/ml (Cal-Rsodate)

Melphalan Injection IP 50mg (Alkacel)

Melphalan Injection IP 50mg (Alkacel)

Monobenzone Cream USP 20% (Albaquin)

Monobenzone Cream USP 20% (Albaquin)

Beclomethasone Dipropionate and Levosalbutamol Inhaler (Aerocort)

Beclomethasone Dipropionate and Levosalbutamol Inhaler (Aerocort)

Calcium Gluconate Injection I. P. 10ml (Aquacalcium)

Calcium Gluconate Injection I. P. 10ml (Aquacalcium)

Looking for some Drug which is not available in India?

We would like to help you sourcing it from the best suppliers across the globe.

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2018 GNHIndia .com. All Rights Reserved.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.